felodipine has been researched along with Alveolar Bone Atrophy in 1 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Felodipine was withdrawn and the diabetes was controlled before dental treatment was initiated." | 1.33 | Felodipine-influenced gingival enlargement in an uncontrolled type 2 diabetic patient. ( Fay, AA; Gapski, R; Satheesh, K, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fay, AA | 1 |
| Satheesh, K | 1 |
| Gapski, R | 1 |
1 other study available for felodipine and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Felodipine-influenced gingival enlargement in an uncontrolled type 2 diabetic patient.
Topics: Alveolar Bone Loss; Anti-Bacterial Agents; Anticholesteremic Agents; Calcium Channel Blockers; Denta | 2005 |